pAtient Reported Outcome in RadiotherApy

Recruiting

• Conditions: C50; C71; D32; C61; Malignant neoplasm of breast; Malignant neoplasm of brain; Benign neoplasm of meninges; Malignant neoplasm of prostate

• Registration Number: DRKS00013896
• Lead Sponsor: Klinikum der Universität München, Campus Großhadern

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2018-08-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Indication for radiotherapy in the planned radiotherapy series at the Department of Radiotherapy, LMU University Hospital, Munich.

Regarding Target Sample Size: The inclusion period is to be two years. No case number estimate is required, as the study is a prospective observational study.

Exclusion Criteria

Contraindications for radiotherapy.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The objective of this study is to assess patient-related endpoints (psychological, physical and social aspects) during standard therapy and follow-up care. In addition, it will be investigated to what extent the results correlate between PRO (patient reported outcomes) and traditional clinical target values (e.g. acute toxicities, radiation dose to risk organs). The query is made via the mobile eHealth application CAREONLINE. Standardized patient- and/or tumor-entity-related questionnaires are provided for querying the experienced symptoms (presence, frequency, strength), abilities, behaviors or psychological sensitivities, which the patient can answer via the app. Standardized questionnaires (e.g. EORTC, FACT-B) are used for this purpose. The frequency of the query varies from daily to weekly, depending on the radiotherapy schedule.